| Autor: |
Roghayeh Kamran Samani, Fatemeh Maghsoudinia, Fatemeh Mehradnia, Seyed Hossein Hejazi, Mohsen Saeb, Tayebe Sobhani, Zohreh Farahbakhsh, Masoud Ayatollahi Mehrgardi, Mohamad Bagher Tavakoli |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Nanomedicine: Nanotechnology, Biology and Medicine. 48:102643 |
| ISSN: |
1549-9634 |
| DOI: |
10.1016/j.nano.2022.102643 |
| Popis: |
Chemoradiotherapy with controlled-release nanocarriers such as sono-sensitive nanodroplets (NDs) can enhance the anticancer activity of chemotherapy medicines and reduces normal tissue side effects. In this study, folic acid-functionalized methotrexate-loaded perfluorohexane NDs with alginate shell (FA-MTX/PFH@alginate NDs) were synthesized, characterized, and their potential for ultrasound-guided chemoradiotherapy of breast cancer was investigated in vitro and in vivo. The cancer cell (4T1) viabilities and surviving fractions after NDs and ultrasound treatments were significantly decreased. However, this reduction was much more significant for ultrasound in combination with X-ray irradiation. The in vitro and in vivo results confirmed that MTX-loaded NDs are highly biocompatible and they have no significant hemolytic activity and organ toxicity. Furthermore, the in vivo results indicated that the FA-MTX/PFH@alginate NDs were accumulated selectively in the tumor region. In conclusion, FA-functionalized MTX/PFH@alginate NDs have a great theranostic performance for ultrasound-controlled drug delivery in combination with radiotherapy of breast cancer. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect